Blood and urine markers for ovarian cancer: a comprehensive review.
about
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cystsp53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer.Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.Challenges related to developing serum-based biomarkers for early ovarian cancer detection.Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.Proteomic identification of fucosylated haptoglobin alpha isoforms in ascitic fluids and its localization in ovarian carcinoma tissues from Mexican patients.Human epididymis protein 4 reference limits and natural variation in a Nordic reference populationA xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancerConventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer.Multi-marker testing for cancer: what can we learn from modern prenatal testing for Trisomy-21.Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer.Ovarian cancer proteomics: Many technologies one goal.Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response.A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC CohortA multiplex platform for the identification of ovarian cancer biomarkersEvaluation of serum mesothelin in malignant and benign ovarian masses.Single and combined use of red cell distribution width, mean platelet volume, and cancer antigen 125 for differential diagnosis of ovarian cancer and benign ovarian tumors.CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer
P2860
Q24651331-EEA6C5D8-6CC1-4761-A05C-27F9A89E8D05Q33725961-8E22AD64-3E60-4AD5-AAD2-E7F73A0FBE9DQ34094060-3B4A39F8-D661-4291-B2F8-8AE651E0061BQ34796143-C52408E3-DBBD-4AEC-91CA-2D01CDB4936EQ34895083-AFB5A258-E8EC-49B4-A446-7433ADB0C62EQ35104034-10804D61-ABC5-4672-A98C-9BCC5A481C5BQ35605987-F01A3BD6-EFC7-4F3C-B546-22D402394BEDQ35736782-EA1305F2-74DC-4D79-A130-2BC50E052C67Q36686826-5CFAE545-AB10-4BC0-999C-1FFF9E36D3FFQ37175042-AFC00DFA-FF8E-4E39-A575-C559EA00251DQ37329737-ADB4F28F-3ECB-4E57-AFEB-FEDE8C26B215Q37817189-D00E93FD-A7E5-420F-8125-2012457D616CQ39408740-730BAC31-417C-4EDE-8219-E6F0F936AE7BQ40810205-64E3600A-7692-4170-B452-DA096147B9A3Q42374131-87827AFD-6FA8-4E91-BA44-495423503A00Q46245510-743D9F2C-9357-4845-B4B9-1D91A8C56EA9Q50054328-3A348ADF-1E1C-44A3-B434-F35380DD1E0CQ57041986-7A70AA1D-6066-4524-9A49-45AD2C3E862F
P2860
Blood and urine markers for ovarian cancer: a comprehensive review.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Blood and urine markers for ovarian cancer: a comprehensive review.
@ast
Blood and urine markers for ovarian cancer: a comprehensive review.
@en
type
label
Blood and urine markers for ovarian cancer: a comprehensive review.
@ast
Blood and urine markers for ovarian cancer: a comprehensive review.
@en
prefLabel
Blood and urine markers for ovarian cancer: a comprehensive review.
@ast
Blood and urine markers for ovarian cancer: a comprehensive review.
@en
P2093
P921
P356
P1433
P1476
Blood and urine markers for ovarian cancer: a comprehensive review.
@en
P2093
Allison F Vitonis
Daniel W Cramer
Kathryn L Terry
Patrick M Sluss
Samuel C Mok
Steven J Skates
P356
10.1155/2004/241982
P577
2004-01-01T00:00:00Z